Milestone Pharmaceuticals (MIST) Operating Expenses (2018 - 2022)
Milestone Pharmaceuticals' (MIST) quarterly Operating Expenses came in at $13.9 million in Q3 2022, up 9.19% YoY from $12.7 million in Q3 2021, and down 4.91% on a QoQ basis from $14.6 million in Q2 2022.
Milestone Pharmaceuticals (MIST) Operating Expenses (2018 - 2022) Analysis & Trends
Milestone Pharmaceuticals (MIST) has 5 years of Operating Expenses data on file, last reported at $13.9 million in Q3 2022.
- Quarterly Operating Expenses rose 9.19% year-over-year to $13.9 million in Q3 2022, while the trailing twelve-month figure through Jun 2023 was $13.9 million (down 66.98% YoY) and the FY2021 annual result came in at $51.1 million, up 14.06% from the prior year.
- Operating Expenses fell to $13.9 million in Q3 2022, from $14.6 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $16.4 million in Q4 2019 to a low of $3.3 million in Q2 2018.
- A 5-year average of $10.7 million and a median of $11.6 million in 2019 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2019 — Operating Expenses jumped 268.62% — and 2020, when it slumped 54.71%.
- Tracing MIST's Operating Expenses over 5 years: stood at $8.5 million in 2018, then surged by 92.93% to $16.4 million in 2019, then tumbled by 54.71% to $7.4 million in 2020, then soared by 97.62% to $14.7 million in 2021, then decreased by 5.73% to $13.9 million in 2022.
- The last three Operating Expenses figures came in at $13.9 million (Q3 2022), $14.6 million (Q2 2022), and $14.7 million (Q4 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.06 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 427.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 541.02 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -784.57 Mn |
| 10 | Milestone Pharmaceuticals | 42.70 Mn | -128.80 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 13.86 Mn |
| Jun 30, 2022 | 14.58 Mn |
| Dec 31, 2021 | 14.70 Mn |
| Sep 30, 2021 | 12.69 Mn |
| Jun 30, 2021 | 12.45 Mn |
| Mar 31, 2021 | 11.23 Mn |
| Dec 31, 2020 | 7.44 Mn |
| Sep 30, 2020 | 11.18 Mn |
| Jun 30, 2020 | 11.58 Mn |
| Mar 31, 2020 | 14.58 Mn |
| Dec 31, 2019 | 16.43 Mn |
| Sep 30, 2019 | 11.65 Mn |
| Jun 30, 2019 | 12.17 Mn |
| Mar 31, 2019 | 8.74 Mn |
| Dec 31, 2018 | 8.52 Mn |
| Sep 30, 2018 | 4.56 Mn |
| Jun 30, 2018 | 3.30 Mn |
| Mar 31, 2018 | 3.53 Mn |